NYSE:ORN - Post Discussion
Post by
whytestocks on Sep 11, 2024 5:45pm
ORYZON Receives "Intention to Grant" Communication for Paten
News; $ORN ORYZON Receives "Intention to Grant" Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality DisorderMADRID and CAMBRIDGE, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the European Patent Office ...
ORN - ORYZON Receives "Intention to Grant" Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
Be the first to comment on this post